PharmaKB logo
Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
AboutPricing
Drug ReportsVACTOSERTIB
VACTOSERTIB
Vactosertib is a small molecule pharmaceutical. It is currently being investigated in clinical studies. The pharmaceutical is active against activin receptor type-1B and TGF-beta receptor type-1.
Download report
Favorite
Events Timeline
Commercial
Clinical
Drug
Target
Variants
Financial
Trends
Safety
Events Timeline
5D
1M
3M
6M
YTD
1Y
2Y
5Y
Max
Events
FDA approval date
EMA approval date
Patent expiration date
Study first post date
Last update post date
Start date
Primary completion date
Completion date
Results first post date
Plot placeholder
Mock data
Subscribe for the real data
Commercial
No data
Clinical
Clinical Trials
21 clinical trials
View more details
Plot placeholder
Mock data
Subscribe for the real data
Indications Phases 4
No data
Indications Phases 3
No data
Indications Phases 2
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
AdenocarcinomaD000230345
Stomach neoplasmsD013274EFO_0003897C16345
Colorectal neoplasmsD015179223
NeoplasmsD009369C80213
Esophageal neoplasmsD004938C15223
Non-small-cell lung carcinomaD002289122
Aggressive fibromatosisD018222D48.11122
Pancreatic neoplasmsD010190EFO_0003860C25212
Myeloproliferative disordersD009196D47.1112
Urologic neoplasmsD014571C64-C6811
Show 8 more
Indications Phases 1
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
Multiple myelomaD009101C90.022
Myelodysplastic syndromesD009190D4622
SyndromeD01357722
Plasma cell neoplasmsD05421911
Healthy volunteers/patients11
PreleukemiaD01128911
LeukemiaD007938C9511
Myeloid leukemia acuteD015470C92.011
Hematologic neoplasmsD01933711
Non-hodgkin lymphomaD008228C85.911
Show 7 more
Indications Without Phase
No data
Epidemiology
Epidemiological information for investigational and approved indications
View more details
Drug
General
Drug common nameVACTOSERTIB
INNvactosertib
Description
Vactosertib is a small molecule pharmaceutical. It is currently being investigated in clinical studies. The pharmaceutical is active against activin receptor type-1B and TGF-beta receptor type-1.
Classification
Small molecule
Drug classserine/threonine kinase inhibitors
Image (chem structure or protein)Loading
Structure (InChI/SMILES or Protein Sequence)
Cc1cccc(-c2[nH]c(CNc3ccccc3F)nc2-c2ccc3ncnn3c2)n1
Identifiers
PDB
CAS-ID1352608-82-2
RxCUI
ChEMBL IDCHEMBL3260567
ChEBI ID
PubChem CID
DrugBank
UNII ID6T4O391P5Y (ChemIDplus, GSRS)
Target
Agency Approved
ACVR1B
ACVR1B
TGFBR1
TGFBR1
Organism
Homo sapiens
Gene name
ACVR1B
Gene synonyms
ACVRLK4, ALK4
NCBI Gene ID
Protein name
activin receptor type-1B
Protein synonyms
activin A receptor, type IB, activin A receptor, type II-like kinase 4, Activin receptor type IB, Activin receptor-like kinase 4, ACTR-IB, ALK-4, Serine/threonine-protein kinase receptor R2, SKR2
Uniprot ID
Mouse ortholog
Acvr1b (11479)
activin receptor type-1B (Q61271)
Alternate
No data
Variants
No data
Financial
No data
Trends
PubMed Central
Top Terms for Disease or Syndrome:
Plot placeholder
Mock data
Subscribe for the real data
Additional graphs summarizing 322 documents
View more details
Safety
Black-box Warning
No Black-box warning
Adverse Events
0 adverse events reported
© 2020-2024 Collaborative Drug Discovery Inc. (CDD) | Terms of Use